Loading...
Tenofovir — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Tenofovir
2025-Q4
Comprehensive analysis of India’s tenofovir export trade — suppliers, buyers, prices, routes, and every shipment record.
76
Shipments
$1.85M
Trade Value
24
Suppliers
19
Buyers
21
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/tenofovir
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s tenofovir trade — 2025-Q4
KEY TAKEAWAY
Tenofovir 2025-Q4 exports total $1.8M across 21 countries, with CIPLA LTD commanding 73.3% market share.
TOTAL SHIPMENTS
76
2025-Q4
EXPORT VALUE
$1.8M
FOB USD
TOTAL QUANTITY
9.4M
units shipped
INDIAN SUPPLIERS
24
unique exporters
GLOBAL BUYERS
19
unique importers
DESTINATIONS
21
countries
MEDIAN UNIT PRICE
$9.82
per unit
TOP-5 SHARE
97.8%
of total USD
BRANDED SHARE
69.7%
53 shipments
DOSAGE FORMS
4
product types
6 KEY FINDINGS
1
CIPLA LTD is India's #1 Tenofovir exporter with $1.4M (73.3% market share).→ §5, Indian Supplier Rankings
2
Tenofovir reached 21 countries, with South Africa as the top destination ($1.6M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 5660) — top 10 suppliers control 99.6% of exports.→ §5, Indian Supplier Rankings
4
84.2% of buyers (16 of 19) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (83.2%) across 4 dosage forms.→ §7, Price Benchmarks
6
21 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 CIPLA LTD leads in volume — how do 24 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian tenofovir exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Tenofovir report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial tenofovir trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian tenofovir suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Tenofovir India trade report
Product scope
Tenofovir
All variants merged — branded and generic formulations of tenofovir
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
76
Every commercial tenofovir trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $43.7K, Nov $1.1M, Dec $666.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$43.7K
Oct USD
6 shipments
2
$1.1M
Nov USD
+2503.6% MoM
3
$666.0K
Dec USD
-41.4% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 2503.6% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $44K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $1.8M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $1.1M rise in Nov, $471K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $44K | 6 shipments |
| Nov | $1.1M | 47 shipments |
| Dec | $666K | 23 shipments |
| Q4 Total | $1.8M | 76 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: South Africa held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: CIPLA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import tenofovir from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 89.0% of India’s 2025-Q4 tenofovir trade ($1.6M). Beyond the top 10 destinations, 21 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 8 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 21 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much tenofovir India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$31K
1.7% of trade
7 countries · 55 shipments
Europe
$111K
6.0% of trade
2 countries · 2 shipments
Americas
$3K
0.2% of trade
3 countries · 3 shipments
Africa
$1.7M
90.6% of trade
8 countries · 15 shipments
Oceania
$28K
1.5% of trade
1 countries · 1 shipments
Fig 4.1 South Africa is the #1 corridor ($1.6M) — 21 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian tenofovir it receives (light = low, dark = high). Orange arcs radiate from India to the top 21 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $1.6M | 6 | CIPLA LTD | $1.4M | MYLAN LABORATORIES LTD | $291K | — | — |
| 2 | Netherlands | $111K | 1 | HETERO LABS LTD | $111K | — | — | — | — |
| 3 | Australia | $28K | 1 | LUPIN LTD | $28K | — | — | — | — |
| 4 | Liberia | $20K | 2 | NAPO EXPORTS PVT LTD | $20K | — | — | — | — |
| 5 | Turkmenistan | $16K | 1 | LIVEALTH BIOPHARMA PVT LTD | $16K | — | — | — | — |
| 6 | Sierra Leone | $7K | 1 | KADAT GLOBAL IMPEX PVT LTD | $7K | — | — | — | — |
| 7 | Bhutan | $6K | 1 | MACLEODS PHARMACEUTICALS LTD | $6K | — | — | — | — |
| 8 | United Arab Emirates | $4K | 42 | DERRIC WOOD | $3K | HOPEWELL SOLUTIONS | $1K | LAWRENCE WALTER | $74 |
| 9 | Iraq | $3K | 6 | VATS INDUSTRIES PVT LTD | $3K | — | — | — | — |
| 10 | Saint Lucia | $2K | 1 | HETERO LABS LTD | $2K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 1.7% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
89.0%
#1 country share
South Africa alone
98.4%
Top 5 share
5 of 21 countries
99.9%
Top 15 share
Long tail of 6 countries = 0.1%
HHI 7966
Destination HHI
Highly concentrated
21
Countries served
Global pharma reach from India
8
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
24 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
CIPLA LTD ($1.4M, 73.3% share) and MYLAN LABORATORIES LTD ($292.2K) together control 89.1% of India’s 2025-Q4 tenofovir trade. The top 5 suppliers hold 97.8%. 24 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian tenofovir suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CIPLA LTD leads by $1.1M over MYLAN LABORATORIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #10 by value but #1 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (39) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #1 by volume to #10 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 24 tenofovir suppliers split into strategic segments
KEY TAKEAWAY
6 suppliers (25%) generate 98.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CIPLA LTD and MYLAN LABORATORIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | DERRIC WOOD | 2 | 1 | $3K |
| 2 | CIPLA LTD | 1 | 1 | $1.4M |
| 3 | MYLAN LABORATORIES LTD | 1 | 2 | $292K |
| 4 | HETERO LABS LTD | 1 | 2 | $113K |
| 5 | LUPIN LTD | 1 | 1 | $28K |
| 6 | NAPO EXPORTS PVT LTD | 1 | 1 | $20K |
| 7 | LIVEALTH BIOPHARMA PVT LTD | 1 | 1 | $16K |
| 8 | KADAT GLOBAL IMPEX PVT LTD | 1 | 1 | $7K |
| 9 | MACLEODS PHARMACEUTICALS LTD | 1 | 1 | $6K |
| 10 | VATS INDUSTRIES PVT LTD | 1 | 1 | $3K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the tenofovir manufacturing hubs
KEY TAKEAWAY
Parel Mumbai Maharashtra and Nashik together account for $1.6M of India’s 2025-Q4 tenofovir trade.
Fig 5.5 Parel Mumbai Maharashtra (1 exporters, $1.4M) and Nashik (1 exporters, $292K) are India’s tenofovir capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
97.8%
Top 5 share
5 of 24 suppliers
99.6%
Top 10 share
10 of 24 suppliers
98.6%
Top 25% share
6 suppliers = 99% USD
HHI 5660
Supplier HHI
Concentrated
24
Total suppliers
shipped Tenofovir in 2025-Q4
17+ cities
Indian hubs
Parel Mumbai Maharashtra and Nashik lead
§5.2 Coming next: 0 exporter deep-dive profiles
Each of the top 0 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
19 importers across 21 countries — who is buying Indian tenofovir and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 17 importers together hold only 91.3% of total USD. 84% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian tenofovir. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MEDPRO PHARMACEUTICA PTY LTD is the #1 importer at $1.4M (73.3%) — top 17 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 17 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
84%
Single-source
16 buyers rely on exactly 1 Indian supplier
5%
Dual-source
1 buyers use 2 Indian suppliers
5%
Multi-source (3–4)
1 buyers diversified across 3–4
5%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source tenofovir from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
South Africa 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MEDPRO PHARMACEUTICA P… | CIPLA LTD | $1.4M | $0.232 | Tablet |
| VIATRIS HEALTHCARE (PT… | MYLAN LABORATORIES LTD | $291K | $0.127 | — |
United Arab Emirates 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EGCSS INTERNATIONAL CO… | HOPEWELL SOLUTIONS | $1K | $6.789 | Tablet |
| EMIRATES POST GROUP | ESR ENTERPRISES | $16.319 | $8.159 | Tablet |
Liberia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ABEER PHARMACEUTICALS | NAPO EXPORTS PVT LTD | $20K | $3.022 | Tablet |
Sierra Leone 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| KRISH MEDICARE PVT LTD | KADAT GLOBAL IMPEX P… | $7K | $1.427 | Tablet |
Bhutan 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CAPITAL PHARMACEUTICAL… | MACLEODS PHARMACEUTI… | $6K | $1.663 | Tablet |
§6.3 Price positioning — top 17 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA… | South Africa | $1.4M | $271K | Premium |
| 2 | VIATRIS HEALTHCARE (… | South Africa | $291K | $291K | Premium |
| 3 | ABEER PHARMACEUTICALS | Liberia | $20K | $10K | Budget |
| 4 | KRISH MEDICARE PVT LTD | Sierra Leone | $7K | $7K | Budget |
| 5 | CAPITAL PHARMACEUTIC… | Bhutan | $6K | $6K | Budget |
| 6 | EMIRATES POST COMPANY | United Arab Emirates | $3K | $70.000 | Budget |
| 7 | EGCSS INTERNATIONAL … | United Arab Emirates | $1K | $1K | Budget |
| 8 | ATLANTA MEDICARE CO … | Thailand | $1K | $1K | Budget |
| 9 | ATLAS TRADING COMPANY | Iraq | $1K | $540.000 | Budget |
| 10 | ARK OF GLO NIG LTD | Nigeria | $904.969 | $905.000 | Budget |
| 11 | FREIGHTER MADE LOGIS… | Ghana | $904.969 | $905.000 | Budget |
| 12 | AMDJERAS FIELD HOSPI… | Chad | $505.268 | $505.000 | Budget |
| 13 | THE PHARMACIST | Cayman Islands | $468.780 | $469.000 | Budget |
| 14 | SUCCESS INTER LINK P… | Singapore | $313.516 | $314.000 | Budget |
| 15 | SALAMA PHARMACUTICAL… | Kenya | $213.140 | $213.000 | Budget |
| 16 | EMIRATES POST GROUP | United Arab Emirates | $16.319 | $16.000 | Budget |
| 17 | ULAN JALILOVICH | Kyrgyzstan | $0.999 | $1.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 17 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 CIPLA LTD → MEDPRO PHARMACEUTICA PTY LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 17 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian tenofovir prices vary by supplier, country and dosage form
KEY TAKEAWAY
Tenofovir prices span 4247× ($0.034 → $142.69). The coefficient of variation is 1.79. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.034 | Lowest observed unit price |
| P5 | $0.095 | 5th percentile |
| P25 | $1.51 | 25th percentile (Q1) |
| Median | $9.82 | 50th percentile (Q2) |
| P75 | $10.81 | 75th percentile (Q3) |
| P95 | $14.50 | 95th percentile |
| Max | $142.69 | Highest observed unit price |
| Mean | $9.51 | Arithmetic average |
| CV | 179% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 NATCO PHARMA LTD prices at $142.69/unit vs market median $9.82.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CIPLA LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MYLAN LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | NATCO PHARMA LTD | Kyrgyzstan | — | 0 | $0.999 | $142.69 | Specialty / small-batch |
| Nov 2025 | MYLAN LABORATORI… | Thailand | Powder | 25 | $1K | $44.61 | Specialty / small-batch |
| Nov 2025 | KALINDI OVERSEAS | Cayman Islands | — | 20 | $468.78 | $23.44 | Specialty / small-batch |
| Oct 2025 | AKASH PHARMA EXP… | Chad | Tablet | 30 | $505.27 | $16.84 | Specialty / small-batch |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 6 | $79.46 | $13.24 | Specialty / small-batch |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 3 | $39.59 | $13.20 | Specialty / small-batch |
| Nov 2025 | DERRIC WOOD | United Arab Emirates | — | 6 | $79.11 | $13.18 | Specialty / small-batch |
| Nov 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 4 | $52.62 | $13.16 | Specialty / small-batch |
| Nov 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 4 | $52.62 | $13.16 | Specialty / small-batch |
| Nov 2025 | DERRIC WOOD | United Arab Emirates | Other | 6 | $78.93 | $13.15 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AARK PHARMACEUTI… | Italy | Tablet | 100 | $3.36 | $0.034 | Small sample / trial shipment |
| Dec 2025 | NEW STAR ENTERPR… | Ghana | Tablet | 4 | $0.153 | $0.038 | Small sample / trial shipment |
| Dec 2025 | HETERO LABS LTD | Netherlands | Tablet | 1.3M | $111K | $0.087 | Bulk volume discount |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 8 | $0.761 | $0.095 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 1 | $0.095 | $0.095 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 3 | $0.286 | $0.095 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 1 | $0.097 | $0.097 | Small sample / trial shipment |
| Nov 2025 | MYLAN LABORATORI… | South Africa | — | 2.3M | $291K | $0.127 | Bulk volume discount |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 7 | $0.889 | $0.127 | Small sample / trial shipment |
| Nov 2025 | CIPLA LTD | South Africa | Tablet | 1.2M | $267K | $0.228 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship tenofovir, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Tenofovir leaves India through 8+ ports. The top 5 (MUMBAI AIR (SAHAR), NHAVA SHEVA SEA (JNPT), HYDERABAD ICD) handle 99.6% of total USD. AIR moves 88% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $1.1M — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 CAPE TOWN is the #1 global destination port — top 23 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 88% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$1.1M
59.9% of USD · 88.2% of ships
SEA
$624K
33.8% of USD · 9.2% of ships
ICD
$111K
6.0% of USD · 1.3% of ships
ROAD
$6K
0.3% of USD · 1.3% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Africa ($1.1M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Iraq is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 5322).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Iraq (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 5,322) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MEDPRO PHARMACEUTICA… | South Africa | CIPLA LTD | $1.4M | 5 | CRITICAL |
| VIATRIS HEALTHCARE (… | South Africa | MYLAN LABORATORI… | $291K | 1 | HIGH |
| ABEER PHARMACEUTICALS | Liberia | NAPO EXPORTS PVT… | $20K | 2 | MEDIUM |
| KRISH MEDICARE PVT LTD | Sierra Leone | KADAT GLOBAL IMP… | $7K | 1 | MEDIUM |
| CAPITAL PHARMACEUTIC… | Bhutan | MACLEODS PHARMAC… | $6K | 1 | MEDIUM |
| EGCSS INTERNATIONAL … | United Arab Emirates | HOPEWELL SOLUTIONS | $1K | 1 | MEDIUM |
| ATLANTA MEDICARE CO … | Thailand | MYLAN LABORATORI… | $1K | 1 | MEDIUM |
| ATLAS TRADING COMPANY | Iraq | VATS INDUSTRIES … | $1K | 2 | MEDIUM |
Conclusion: 16 buyers depend on exactly one Indian supplier, representing $1.7M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Liberia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Turkmenistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sierra Leone | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Bhutan | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Saint Lucia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ethiopia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in South Africa | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Iraq lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (2 suppliers) | This Q | HIGH |
| A6 | Enter Netherlands (1 suppliers) | This Q | MED |
| A8 | Build Netherlands distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 2 | $1.6M | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Netherlands | Other | 1 | $111K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Australia | Other | 1 | $28K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Liberia | Africa | 1 | $20K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Turkmenistan | Asia | 1 | $16K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Sierra Leone | Africa | 1 | $7K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Bhutan | Asia | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | United Arab Emirates | Other | 4 | $4K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 9 | Iraq | Other | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Saint Lucia | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Singapore | Asia | 2 | $1K | -97.5% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Thailand | Asia | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Ghana | Africa | 2 | $905 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Nigeria | Africa | 1 | $905 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Ethiopia | Africa | 1 | $699 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 76 2025-Q4 Tenofovir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tenofovir
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 76 2025-Q4 tenofovir shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian tenofovir shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
76
across all regions
TOTAL USD
$1.85M
2025-Q4 FOB value
UNITS
9.4M
tablets, capsules, etc.
SUPPLIERS
24
Indian exporters
BUYERS
19
global importers
COUNTRIES
21
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $1.67M (90.6%), spanning 8 countries.
24 Indian suppliers shipped to 19 buyers across 21 countries — average shipment value $24K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
8 countries · 15 shipments · $1.67M · 9 Indian suppliers · 10 buyers
SHIPMENTS
15
USD
$1.67M
COUNTRIES
8
SUPPLIERS
9
BUYERS
10
HHI
6,837
concentrated
Top 8 destination countries in Africa
1
South Africa (98.2%)
$1.64M
2
Liberia (1.2%)
$20K
3
Sierra Leone (0.4%)
$7K
4
Ghana (0.1%)
$905.12
5
Nigeria (0.1%)
$904.97
6
Ethiopia (0.0%)
$699.44
7
Chad (0.0%)
$505.27
8
Kenya (0.0%)
$213.14
Top 9 Indian suppliers into Africa
1
CIPLA LTD
$1.35M
2
MYLAN LABORATORIES LTD
$291K
3
NAPO EXPORTS PVT LTD
$20K
4
KADAT GLOBAL IMPEX PVT LTD
$7K
5
BAKER & DAVIS PVT LTD
$2K
6
MATOSHREE HEALTH CARE PVT LTD
$699.44
7
AKASH PHARMA EXPORTS
$505.27
8
M T MADON EXPORTS
$213.14
9
NEW STAR ENTERPRISES
$0.153
Top 8 Africa importers
1
MEDPRO PHARMACEUTICA PTY LTD · South Africa
$1.35M
2
VIATRIS HEALTHCARE (PTY) LTD · South Africa
$291K
3
ABEER PHARMACEUTICALS · Liberia
$20K
4
KRISH MEDICARE PVT LTD · Sierra Leone
$7K
5
ARK OF GLO NIG LTD · Nigeria
$904.97
6
FREIGHTER MADE LOGISTICS LTD · Ghana
$904.97
7
AMDJERAS FIELD HOSPITAL · Chad
$505.27
8
SALAMA PHARMACUTICALS LTD · Kenya
$213.14
Top 2 dosage forms
1
Tablet
$1.38M
2
Unknown
$291K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $27K | $7K |
| Nov | 6 | $1.09M | $182K |
| Dec | 5 | $555K | $111K |
Shipment register · 15 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 5 shipments · $1.35M | |||||||||||
| 1 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 1.2M | NOS | $0.228 | $267K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 2 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 1.2M | NOS | $0.229 | $266K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 3 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 1.2M | NOS | $0.229 | $267K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 4 | Dec 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 1.2M | NOS | $0.235 | $272K | NHAVA SHEVA SEA (JNPT) | Cape Town | SEA |
| 5 | Dec 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 1.2M | NOS | $0.242 | $282K | NHAVA SHEVA SEA (JNPT) | Cape Town | SEA |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 1 shipments · $291K | |||||||||||
| 6 | Nov 2025 | VIATRIS HEALTHCARE (PTY) LTD | South Africa | 2.3M | NOS | $0.127 | $291K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR | |
| SUPPLIER #3 — NAPO EXPORTS PVT LTD · 2 shipments · $20K | |||||||||||
| 7 | Oct 2025 | ABEER PHARMACEUTICALS | Liberia | Tablet | 3.2K | NOS | $2.89 | $9K | NHAVA SHEVA SEA (JNPT) | Monrovia | SEA |
| 8 | Oct 2025 | ABEER PHARMACEUTICALS | Liberia | Tablet | 3.2K | NOS | $3.15 | $10K | NHAVA SHEVA SEA (JNPT) | Monrovia | SEA |
| SUPPLIER #4 — KADAT GLOBAL IMPEX PVT LTD · 1 shipments · $7K | |||||||||||
| 9 | Oct 2025 | KRISH MEDICARE PVT LTD | Sierra Leone | Tablet | 4.9K | NOS | $1.43 | $7K | MUNDRA SEA | FREETOWN | SEA |
| SUPPLIER #5 — BAKER & DAVIS PVT LTD · 2 shipments · $2K | |||||||||||
| 10 | Nov 2025 | ARK OF GLO NIG LTD | Nigeria | Tablet | 600 | PCS | $1.51 | $904.97 | MUMBAI AIR (SAHAR) | LAGOS | AIR |
| 11 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 600 | NOS | $1.51 | $904.97 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #6 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $699.44 | |||||||||||
| 12 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Tablet | 300 | NOS | $2.33 | $699.44 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #7 — AKASH PHARMA EXPORTS · 1 shipments · $505.27 | |||||||||||
| 13 | Oct 2025 | AMDJERAS FIELD HOSPITAL | Chad | Tablet | 30 | NOS | $16.84 | $505.27 | COCHIN SEA | N'DJAMENA | AIR |
| SUPPLIER #8 — M T MADON EXPORTS · 1 shipments · $213.14 | |||||||||||
| 14 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Tablet | 30 | NOS | $7.10 | $213.14 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #9 — NEW STAR ENTERPRISES · 1 shipments · $0.153 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 4 | NOS | $0.038 | $0.153 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
7 countries · 55 shipments · $31K · 11 Indian suppliers · 10 buyers
SHIPMENTS
55
USD
$31K
COUNTRIES
7
SUPPLIERS
11
BUYERS
10
HHI
3,041
concentrated
Top 7 destination countries in Asia
1
Turkmenistan (49.5%)
$16K
2
Bhutan (19.1%)
$6K
3
United Arab Emirates (13.3%)
$4K
4
Iraq (10.3%)
$3K
5
Singapore (4.3%)
$1K
6
Thailand (3.5%)
$1K
7
Kyrgyzstan (0.0%)
$0.999
Top 11 Indian suppliers into Asia
1
LIVEALTH BIOPHARMA PVT LTD
$16K
2
MACLEODS PHARMACEUTICALS LTD
$6K
3
VATS INDUSTRIES PVT LTD
$3K
4
DERRIC WOOD
$3K
5
HOPEWELL SOLUTIONS
$1K
6
MYLAN LABORATORIES LTD
$1K
7
LEOWIN HEALTHCARE LLP
$1K
8
SANITAS MEDTECH INSTITUTE PVT LTD
$313.52
9
LAWRENCE WALTER
$74.47
10
ESR ENTERPRISES
$16.32
11
NATCO PHARMA LTD
$0.999
Top 8 Asia importers
1
CAPITAL PHARMACEUTICAL AND MEDICAL · Bhutan
$6K
2
EMIRATES POST COMPANY · United Arab Emirates
$3K
3
EGCSS INTERNATIONAL CO.FZ · United Arab Emirates
$1K
4
ATLANTA MEDICARE CO LTD · Thailand
$1K
5
ATLAS TRADING COMPANY · Iraq
$1K
6
SUCCESS INTER LINK PTE LTD · Singapore
$313.52
7
EMIRATES POST GROUP · United Arab Emirates
$16.32
8
ULAN JALILOVICH · Kyrgyzstan
$0.999
Top 5 dosage forms
1
Injection
$16K
2
Tablet
$13K
3
Unknown
$1K
4
Powder
$1K
5
Other
$78.93
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $17K | $8K |
| Nov | 37 | $14K | $386.26 |
| Dec | 16 | $573.10 | $35.82 |
Shipment register · 55 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LIVEALTH BIOPHARMA PVT LTD · 1 shipments · $16K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Turkmenistan | Injection | 30.2K | VLS | $0.515 | $16K | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
| SUPPLIER #2 — MACLEODS PHARMACEUTICALS LTD · 1 shipments · $6K | |||||||||||
| 2 | Nov 2025 | CAPITAL PHARMACEUTICAL AND MEDICAL | Bhutan | Tablet | 3.6K | NOS | $1.66 | $6K | JAIGAON LCS | Phuntsholing | ROAD |
| SUPPLIER #3 — VATS INDUSTRIES PVT LTD · 6 shipments · $3K | |||||||||||
| 3 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | 10 | NOS | $10.81 | $108.08 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 4 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | 90 | NOS | $10.81 | $972.70 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 5 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 10 | NOS | $10.81 | $108.08 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 90 | NOS | $10.81 | $972.69 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 10 | NOS | $10.81 | $108.08 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 90 | NOS | $10.81 | $972.70 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #4 — DERRIC WOOD · 39 shipments · $3K | |||||||||||
| 9 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Other | 6 | PCS | $13.15 | $78.93 | DELHI AIR | DUBAI | AIR |
| 10 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $13.16 | $52.62 | DELHI AIR | DUBAI | AIR |
| 11 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.88 | $59.26 | DELHI AIR | DUBAI | AIR |
| 12 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $13.15 | $105.21 | DELHI AIR | DUBAI | AIR |
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $13.15 | $105.21 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.88 | $59.26 | DELHI AIR | DUBAI | AIR |
| 15 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $13.16 | $52.62 | DELHI AIR | DUBAI | AIR |
| 16 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.82 | $58.90 | DELHI AIR | DUBAI | AIR |
| 17 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 9 | PCS | $9.83 | $88.43 | DELHI AIR | DUBAI | AIR | |
| 18 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | 6 | PCS | $9.82 | $58.90 | DELHI AIR | DUBAI | AIR | |
| 19 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 9 | PCS | $9.83 | $88.43 | DELHI AIR | DUBAI | AIR |
| 20 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 16 | PCS | $9.82 | $157.07 | DELHI AIR | DUBAI | AIR |
| 21 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 106 | PCS | $6.39 | $677.16 | DELHI AIR | DUBAI | AIR |
| 22 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.97 | $59.84 | DELHI AIR | DUBAI | AIR |
| 23 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $13.09 | $26.18 | DELHI AIR | DUBAI | AIR |
| 24 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 3 | PCS | $9.83 | $29.48 | DELHI AIR | DUBAI | AIR | |
| 25 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 5 | PCS | $9.82 | $49.09 | DELHI AIR | DUBAI | AIR | |
| 26 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $13.10 | $13.10 | DELHI AIR | DUBAI | AIR |
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.83 | $58.96 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.83 | $58.96 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.89 | $59.36 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 39 | PCS | $0.269 | $10.51 | DELHI AIR | DUBAI | AIR | |
| 31 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 20 | PCS | $1.77 | $35.47 | DELHI AIR | DUBAI | AIR | |
| 32 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $11.27 | $67.62 | DELHI AIR | DUBAI | AIR |
| 33 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 6 | PCS | $13.18 | $79.11 | DELHI AIR | DUBAI | AIR | |
| 34 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | PCS | $13.20 | $39.59 | DELHI AIR | DUBAI | AIR |
| 35 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $9.90 | $118.75 | DELHI AIR | DUBAI | AIR |
| 36 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $10.17 | $121.99 | DELHI AIR | DUBAI | AIR |
| 37 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $9.87 | $59.19 | DELHI AIR | DUBAI | AIR |
| 38 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 39 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 40 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $0.095 | $0.095 | DELHI AIR | DUBAI | AIR |
| 41 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $0.097 | $0.097 | DELHI AIR | DUBAI | AIR |
| 42 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | PCS | $0.095 | $0.286 | DELHI AIR | DUBAI | AIR |
| 43 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 7 | PCS | $0.127 | $0.889 | DELHI AIR | DUBAI | AIR |
| 44 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $0.095 | $0.761 | DELHI AIR | DUBAI | AIR |
| 45 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $10.08 | $90.74 | DELHI AIR | DUBAI | AIR |
| 46 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.08 | $19.42 | DELHI AIR | DUBAI | AIR |
| 47 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $13.24 | $79.46 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #5 — HOPEWELL SOLUTIONS · 1 shipments · $1K | |||||||||||
| 48 | Nov 2025 | EGCSS INTERNATIONAL CO.FZ | United Arab Emirates | Tablet | 200 | NOS | $6.79 | $1K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #6 — MYLAN LABORATORIES LTD · 1 shipments · $1K | |||||||||||
| 49 | Nov 2025 | ATLANTA MEDICARE CO LTD | Thailand | Powder | 25 | KGS | $44.61 | $1K | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| SUPPLIER #7 — LEOWIN HEALTHCARE LLP · 2 shipments · $1K | |||||||||||
| 50 | Oct 2025 | UNLISTED BUYER | Singapore | Tablet | 200 | NOS | $5.01 | $1K | AHMEDABAD AIR | SINGAPORE | AIR |
| 51 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 5 | NOS | $5.10 | $25.51 | AHMEDABAD AIR | SINGAPORE | AIR |
| SUPPLIER #8 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $313.52 | |||||||||||
| 52 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 51 | NOS | $6.15 | $313.52 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #9 — LAWRENCE WALTER · 1 shipments · $74.47 | |||||||||||
| 53 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $12.41 | $74.47 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #10 — ESR ENTERPRISES · 1 shipments · $16.32 | |||||||||||
| 54 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 2 | NOS | $8.16 | $16.32 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #11 — NATCO PHARMA LTD · 1 shipments · $0.999 | |||||||||||
| 55 | Nov 2025 | ULAN JALILOVICH | Kyrgyzstan | 0 | GMS | $142.69 | $0.999 | MUMBAI AIR (SAHAR) | BISHKEK | AIR | |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 2 shipments · $111K · 2 Indian suppliers · 1 buyers
SHIPMENTS
2
USD
$111K
COUNTRIES
2
SUPPLIERS
2
BUYERS
1
HHI
9,999
concentrated
Top 2 destination countries in Europe
1
Netherlands (100.0%)
$111K
2
Italy (0.0%)
$3.36
Top 2 Indian suppliers into Europe
1
HETERO LABS LTD
$111K
2
AARK PHARMACEUTICALS
$3.36
Top 0 Europe importers
Top 1 dosage forms
1
Tablet
$111K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 2 | $111K | $55K |
Shipment register · 2 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 1 shipments · $111K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Netherlands | Tablet | 1.3M | NOS | $0.087 | $111K | HYDERABAD ICD | ROTTERDAM | ICD |
| SUPPLIER #2 — AARK PHARMACEUTICALS · 1 shipments · $3.36 | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Italy | Tablet | 100 | PCS | $0.034 | $3.36 | DELHI AIR | MILAN | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
3 countries · 3 shipments · $3K · 3 Indian suppliers · 2 buyers
SHIPMENTS
3
USD
$3K
COUNTRIES
3
SUPPLIERS
3
BUYERS
2
HHI
5,717
concentrated
Top 3 destination countries in Americas
1
Saint Lucia (73.1%)
$2K
2
Cayman Islands (16.4%)
$468.78
3
Venezuela (10.5%)
$301.20
Top 3 Indian suppliers into Americas
1
HETERO LABS LTD
$2K
2
KALINDI OVERSEAS
$468.78
3
GALAXY SUPER SPECIALITY
$301.20
Top 1 Americas importers
1
THE PHARMACIST · Cayman Islands
$468.78
Top 2 dosage forms
1
Tablet
$2K
2
Unknown
$468.78
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 3 | $3K | $952.49 |
| Dec | 0 | $0.0000 | — |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 1 shipments · $2K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Saint Lucia | Tablet | 516 | NOS | $4.05 | $2K | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #2 — KALINDI OVERSEAS · 1 shipments · $468.78 | |||||||||||
| 2 | Nov 2025 | THE PHARMACIST | Cayman Islands | 20 | NOS | $23.44 | $468.78 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR | |
| SUPPLIER #3 — GALAXY SUPER SPECIALITY · 1 shipments · $301.20 | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 30 | NOS | $10.04 | $301.20 | DELHI AIR | MADRID | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $28K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$28K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Australia (100.0%)
$28K
Top 1 Indian suppliers into Oceania
1
LUPIN LTD
$28K
Top 0 Oceania importers
Top 1 dosage forms
1
Tablet
$28K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $28K | $28K |
| Dec | 0 | $0.0000 | — |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LUPIN LTD · 1 shipments · $28K | |||||||||||
| 1 | Nov 2025 | UNKNOWN BUYER | Australia | Tablet | 3.0K | NOS | $9.44 | $28K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 24 Indian tenofovir exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped tenofovir in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | CIPLA LTD | PAREL MUMBAI MAHARASHTRA | 5 | $1.35M | Tablet | Africa |
| 2 | MYLAN LABORATORIES LTD | NASHIK | 2 | $292K | Powder | Asia, Africa |
| 3 | HETERO LABS LTD | HYDERABAD | 2 | $113K | Tablet | Americas, Europe |
| 4 | LUPIN LTD | Santacruz (East) | 1 | $28K | Tablet | Oceania |
| 5 | NAPO EXPORTS PVT LTD | Indore | 2 | $20K | Tablet | Africa |
| 6 | LIVEALTH BIOPHARMA PVT LTD | MUMBAI | 1 | $16K | Injection | Asia |
| 7 | KADAT GLOBAL IMPEX PVT LTD | MUMBAI | 1 | $7K | Tablet | Africa |
| 8 | MACLEODS PHARMACEUTICALS LTD | KACHIGAM DAMAN U T | 1 | $6K | Tablet | Asia |
| 9 | VATS INDUSTRIES PVT LTD | NEW DELHI | 6 | $3K | Tablet | Asia |
| 10 | DERRIC WOOD | SUBHASH PLACE | 39 | $3K | Other, Tablet | Asia |
| 11 | BAKER & DAVIS PVT LTD | MUMBAI | 2 | $2K | Tablet | Africa |
| 12 | HOPEWELL SOLUTIONS | MUMBAI | 1 | $1K | Tablet | Asia |
| 13 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 2 | $1K | Tablet | Asia |
| 14 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $699.44 | Tablet | Africa |
| 15 | AKASH PHARMA EXPORTS | PALAKKAD | 1 | $505.27 | Tablet | Africa |
| 16 | KALINDI OVERSEAS | MUMBAI | 1 | $468.78 | Americas | |
| 17 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $313.52 | Tablet | Asia |
| 18 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $301.20 | Tablet | Americas |
| 19 | M T MADON EXPORTS | MUMBAI | 1 | $213.14 | Tablet | Africa |
| 20 | LAWRENCE WALTER | DELHI | 1 | $74.47 | Tablet | Asia |
| 21 | ESR ENTERPRISES | NAGPUR | 1 | $16.32 | Tablet | Asia |
| 22 | AARK PHARMACEUTICALS | NEW DELHI | 1 | $3.36 | Tablet | Europe |
| 23 | NATCO PHARMA LTD | HYDERABAD | 1 | $0.999 | Asia | |
| 24 | NEW STAR ENTERPRISES | MUMBAI | 1 | $0.153 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 17 global tenofovir importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian tenofovir in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | 5 | $1.35M | CIPLA LTD | Tablet |
| 2 | VIATRIS HEALTHCARE (PTY) LTD | South Africa | 1 | $291K | MYLAN LABORATORIES LTD | |
| 3 | ABEER PHARMACEUTICALS | Liberia | 2 | $20K | NAPO EXPORTS PVT LTD | Tablet |
| 4 | KRISH MEDICARE PVT LTD | Sierra Leone | 1 | $7K | KADAT GLOBAL IMPEX P… | Tablet |
| 5 | CAPITAL PHARMACEUTICAL AND MEDICAL | Bhutan | 1 | $6K | MACLEODS PHARMACEUTI… | Tablet |
| 6 | EMIRATES POST COMPANY | United Arab Emirates | 38 | $3K | DERRIC WOOD | Other, Tablet |
| 7 | EGCSS INTERNATIONAL CO.FZ | United Arab Emirates | 1 | $1K | HOPEWELL SOLUTIONS | Tablet |
| 8 | ATLANTA MEDICARE CO LTD | Thailand | 1 | $1K | MYLAN LABORATORIES LTD | Powder |
| 9 | ATLAS TRADING COMPANY | Iraq | 2 | $1K | VATS INDUSTRIES PVT … | |
| 10 | ARK OF GLO NIG LTD | Nigeria | 1 | $904.97 | BAKER & DAVIS PVT LTD | Tablet |
| 11 | FREIGHTER MADE LOGISTICS LTD | Ghana | 1 | $904.97 | BAKER & DAVIS PVT LTD | Tablet |
| 12 | AMDJERAS FIELD HOSPITAL | Chad | 1 | $505.27 | AKASH PHARMA EXPORTS | Tablet |
| 13 | THE PHARMACIST | Cayman Islands | 1 | $468.78 | KALINDI OVERSEAS | |
| 14 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $313.52 | SANITAS MEDTECH INST… | Tablet |
| 15 | SALAMA PHARMACUTICALS LTD | Kenya | 1 | $213.14 | M T MADON EXPORTS | Tablet |
| 16 | EMIRATES POST GROUP | United Arab Emirates | 1 | $16.32 | ESR ENTERPRISES | Tablet |
| 17 | ULAN JALILOVICH | Kyrgyzstan | 1 | $0.999 | NATCO PHARMA LTD |
This report covers 76 2025-Q4 Tenofovir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tenofovir
Talk to our trade analyst
Need a custom tenofovir report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/tenofovir
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Tenofovir product page
Live data, supplier directory, price trends, and trade route analysis